Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.520
-0.012 (-2.29%)
At close: Nov 22, 2024, 4:00 PM
0.525
+0.005 (0.94%)
After-hours: Nov 22, 2024, 6:34 PM EST
Eterna Therapeutics Market Cap
Eterna Therapeutics has a market cap or net worth of $26.71 million as of November 22, 2024. Its market cap has increased by 317.42% in one year.
Market Cap
26.71M
Enterprise Value
60.15M
1-Year Change
317.42%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since December 1, 1998, Eterna Therapeutics's market cap has increased from $21.10M to $26.71M, an increase of 26.61%. That is a compound annual growth rate of 0.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 31.60M | 225.77% |
Dec 29, 2023 | 9.70M | 2.11% |
Dec 30, 2022 | 9.50M | -95.62% |
Dec 31, 2021 | 217.00M | 3,187.88% |
Dec 31, 2020 | 6.60M | 3.13% |
Dec 31, 2019 | 6.40M | 14.29% |
Dec 31, 2018 | 5.60M | -47.17% |
Dec 29, 2017 | 10.60M | -44.79% |
Dec 30, 2016 | 19.20M | 29.73% |
Dec 31, 2015 | 14.80M | -63.55% |
Dec 31, 2014 | 40.60M | -10.18% |
Dec 31, 2013 | 45.20M | 203.36% |
Dec 31, 2012 | 14.90M | -1.97% |
Dec 30, 2011 | 15.20M | -34.20% |
Dec 31, 2010 | 23.10M | -15.07% |
Dec 31, 2009 | 27.20M | 262.67% |
Dec 31, 2008 | 7.50M | -78.07% |
Dec 31, 2007 | 34.20M | -54.22% |
Dec 29, 2006 | 74.70M | -6.74% |
Dec 30, 2005 | 80.10M | -52.55% |
Dec 31, 2004 | 168.80M | -3.87% |
Dec 31, 2003 | 175.60M | 272.03% |
Dec 31, 2002 | 47.20M | 42.17% |
Dec 31, 2001 | 33.20M | 52.29% |
Dec 29, 2000 | 21.80M | -79.57% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Co-Diagnostics | 33.21M |
Moolec Science | 32.87M |
HOOKIPA Pharma | 32.79M |
Passage Bio | 31.73M |
Lantern Pharma | 31.65M |
Curis | 31.00M |
Citius Pharmaceuticals | 30.71M |
BioVie | 30.50M |